Health Condition 1: null- 1 Children with recurrent respiratory infections. 2 Children with recurrent G.I.T. diseases. 3 Children with recurrent fever. 4 Children with other recurrent diseases
Conditions
Interventions
Intervention1: Abhaya Ghrita: Dose and Duration: The proposed trial drug Abhaya ghrita will be prescribed in doses according to body weight of children (180- 200 /kg/day) for 12 weeks & follow-up will
Sponsors
National Institute of Ayurveda Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children aged from 06 months to 05years of either sex. 2. Children with recurrent respiratory infections. 3. Children with recurrent G.I.T. diseases. 4. Children with recurrent fever. 5. Children with other recurrent diseases
Exclusion criteria
Exclusion criteria: 1. Subjects suffering from major systemic illness necessitating long term treatment. 2. Subjects with evidence of malignancy. 3. Subjects with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S.creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction (asthmatic and COPD patients) 4. Co-morbidity like TB, UTI and bleeding disorders etc. 5. H/o hypersensitivity to any of the trial drug or their ingredients. 6. Subjects who have completed participation in any other clinical trial during the past six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To decrease the morbidity status in children with trial drugTimepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To observe the demographic status of morbidity in children in a defined population. 2. To observe the immunomodulatory effect of Abhaya ghritaTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactDr Krishna Bahadur Singh
National Institute of Ayurveda Jaipur
Outcome results
None listed